News & Announcements

August 2023

Dr. Caitlin Gerdts receives Society of Family Planning’s 2023 lifetime achievement award

August 22, 2023 – Today, the Society of Family Planning announced that Ibis’s Vice President for Research, Dr. Caitlin Gerdts , has received their 2023 Lifetime Achievement Award , which honors individuals who have dedicated their careers to advancing the science of abortion and...
July 2023

FDA approves the first-ever over-the-counter birth control pill in the United States

July 13, 2023 - Today, in a historic move for reproductive health that could transform contraception access, the United States Food and Drug Administration (FDA) approved Opill, a progestin-only birth control pill (POP), for over-the-counter (OTC) use. After a comprehensive review of the data and a...
June 2023

Biden issues executive order on improving access to contraception

June 26, 2023 – Last Friday, the Biden Administration issued an executive order on “Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services” . The executive order includes an explicit directive to the Secretaries of the Treasury, Labor and HHS...
June 2023

One year after Dobbs, Ibis remains committed to expanding abortion access

Cambridge, MA, June 23, 2023 – On June 24, 2022, The US Supreme Court released a final decision on Dobbs v. Jackson Women’s Health Organization , which eliminated constitutional protections of the right to abortion care established by Roe v. Wade in 1973. While the protections granted...
June 2023

Ibis attends the 2023 South Africa AIDS Conference

May 2023

FDA advisory committee votes unanimously to recommend Opill for over-the-counter use

May 10, 2023 – Today, in a landmark step for reproductive health, a joint FDA advisory committee voted unanimously to allow a birth control pill to be offered over the counter (OTC). The advisory committee vote reflects the decades of science showing that birth control pills are safe and...